Track changes in symptom frequency, severity, and quality of life rather than expecting every symptom to disappear immediately
At Prime Surgicare, GLP-1 treatment is: Prescribed by a board-certified bariatric and metabolic surgeon Individually dosed after medical evaluation Adjusted based on real response and tolerance Monitored for safety and effectiveness Supported with nutrition and lifestyle guidance This approach is designed for sustainable weight reduction not short-term appetite suppression
This timeline assumes Phase 3 trials complete in late 2026, FDA submission occurs in early 2027, and the review process takes 612 months
Program availability, pricing, and eligibility may vary and are subject to insurance coverage, copays, and determinations made at the time of consultation
Serving ZIPs 33462, 33460, 33461